日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Donor Search and Selection Strategy to Facilitate Comparable Transplant Rates across Donor Search Prognosis Groups: A Report from the BMT CTN 1702 Trial

供体搜索和选择策略旨在促进不同供体搜索预后组之间移植率的可比性:来自 BMT CTN 1702 试验的报告

Pidala, Joseph; Logan, Brent; Lee, Stephanie J; Shaw, Bronwen E; Devine, Steven; Ciurea, Stefan O; Horowitz, Mary; He, Naya; Pusic, Iskra; Srour, Samer A; Arai, Sally; Juckett, Mark; Uberti, Joseph; Hill, LaQuisa; Vasu, Sumithira; Hogan, William J; Hayes-Lattin, Brandon; Westervelt, Peter; Bashey, Asad; Farhadfar, Nosha; Grunwald, Michael R; Leifer, Eric; Symons, Heather; Saad, Ayman; Vogel, Jenny; Erickson, Connor; Buck, Kelly; Dehn, Jason G

Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 Trial

基于供体搜索预后的异基因细胞移植机会:BMT CTN 1702 试验

Dehn, Jason G; Logan, Brent; Lee, Stephanie J; Shaw, Bronwen E; Devine, Steven; Ciurea, Stefan O; Horowitz, Mary; He, Naya; Pusic, Iskra; Srour, Samer A; Arai, Sally; Juckett, Mark; Uberti, Joseph; Hill, LaQuisa; Vasu, Sumithira; Hogan, William J; Hayes-Lattin, Brandon; Westervelt, Peter; Bashey, Asad; Farhadfar, Nosha; Grunwald, Michael R; Leifer, Eric; Symons, Heather; Saad, Ayman; Vogel, Jenny; Erickson, Connor; Buck, Kelly; Pidala, Joseph

Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation

来自血液和骨髓移植临床试验网络1702的主要结果:替代供体异基因移植的临床移植相关长期结果

Lee, Stephanie J; Logan, Brent; Horowitz, Mary M; Dehn, Jason G; Pidala, Joseph; Grunwald, Michael R; Westervelt, Peter; Farhadfar, Nosha; Hogan, William J; Bashey, Asad; Hayes-Lattin, Brandon; Hill, LaQuisa; Brunstein, Claudio; Arai, Sally; Srour, Samer A; Symons, Heather; Uberti, Joseph; Vasu, Sumithira; Pusic, Iskra; Juckett, Mark; Leifer, Eric; He, Naya; Devine, Steven; Shaw, Bronwen E; Ciurea, Stefan O

Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation

伊他替尼用于预防单倍体移植中的移植物抗宿主病和细胞因子释放综合征

Abboud, Ramzi; Schroeder, Mark A; Rettig, Michael P; Jayasinghe, Reyka G; Gao, Feng; Eisele, Jeremy; Gehrs, Leah; Ritchey, Julie; Choi, Jaebok; Abboud, Camille N; Pusic, Iskra; Jacoby, Meagan; Westervelt, Peter; Christopher, Matthew; Cashen, Amanda; Ghobadi, Armin; Stockerl-Goldstein, Keith; Uy, Geoffrey L; DiPersio, John F

Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response

监测克隆负荷可作为骨髓增生异常肿瘤治疗反应的替代指标,以替代原始细胞计数。

Jacoby, Meagan A; Duncavage, Eric D; Khanna, Ajay; Chang, Gue Su; Nonavinkere Srivatsan, Sridhar; Miller, Christopher A; Gao, Feng; Robinson, Josh; Shao, Jin; Fulton, Robert S; Fronick, Catrina C; O'Laughlin, Michelle; Heath, Sharon E; Brendel, Kimberly; Chavez, Monique; DiPersio, John F; Abboud, Camille N; Stockerl-Goldstein, Keith; Westervelt, Peter; Cashen, Amanda; Pusic, Iskra; Oh, Stephen T; Welch, John S; Wells, Denise A; Loken, Michael R; Uy, Geoffrey L; Walter, Matthew J

SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study

造血干细胞移植或嵌合抗原受体T细胞疗法后第一年接种SARS-CoV-2疫苗:一项前瞻性、多中心、观察性研究

Hill, Joshua A; Martens, Michael J; Young, Jo-Anne H; Bhavsar, Kavita; Kou, Jianqun; Chen, Min; Lee, Lik Wee; Baluch, Aliyah; Dhodapkar, Madhav V; Nakamura, Ryotaro; Peyton, Kristin; Howard, Dianna S; Ibrahim, Uroosa; Shahid, Zainab; Armistead, Paul; Westervelt, Peter; McCarty, John; McGuirk, Joseph; Hamadani, Mehdi; DeWolf, Susan; Hosszu, Kinga; Sharon, Elad; Spahn, Ashley; Toor, Amir A; Waldvogel, Stephanie; Greenberger, Lee M; Auletta, Jeffery J; Horowitz, Mary M; Riches, Marcie L; Perales, Miguel-Angel

Blinatumomab consolidation post-autologous stem cell transplantation in patients with diffuse large B-cell lymphoma

Blinatumomab 巩固治疗弥漫性大B细胞淋巴瘤患者自体干细胞移植后

Ghobadi, Armin; Foley, Nicole C; Cohen, Jared; Rettig, Michael P; Cashen, Amanda F; Gehrs, Leah; Christ, Stephanie; Street, Emily; Wallace, Nicholas; Ritchey, Julie; Mehta-Shah, Neha; Westervelt, Peter; Fehniger, Todd A; Kahl, Brad; Bartlett, Nancy L; DiPersio, John F

Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study

半乳糖凝集素-3预测减低强度异基因造血干细胞移植后急性移植物抗宿主病和总体死亡率:一项BMT-CTN生物样本库研究

McCarthy, Philip L; Attwood, Kristopher M; Liu, Xiaojun; Chen, George L; Minderman, Hans; Alousi, Amin; Bashey, Asad; Lowsky, Robert; Miklos, David B; Hansen, John; Westervelt, Peter; Yanik, Gregory; Waller, Edmund K; Howard, Alan; Blazar, Bruce R; Wallace, Paul K; Reshef, Ran; Horowitz, Mary M; Maziarz, Richard T; Levine, John E; Mohammadpour, Hemn

Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102

降低强度异基因造血干细胞移植治疗高危骨髓增生异常综合征老年患者的成本效益:BMT CTN 1102 分析

Saber, Wael; Bansal, Aasthaa; Li, Lily; Scott, Bart L; Sangaralingham, Lindsey R; Thao, Viengneesee; Roth, Joshua A; Wright, Winona; Steuten, Lotte M G; Pidala, Joseph A; Mishra, Asmita; Maziarz, Richard T; Westervelt, Peter; McGuirk, Joseph P; Cutler, Corey; Nakamura, Ryotaro; Ramsey, Scott D

SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101)

造血干细胞移植或嵌合抗原受体T细胞疗法后第一年接种SARS-CoV-2疫苗:一项前瞻性、多中心、观察性研究(BMT CTN 2101)

Hill, Joshua A; Martens, Michael J; Young, Jo-Anne H; Bhavsar, Kavita; Kou, Jianqun; Chen, Min; Lee, Lik Wee; Baluch, Aliyah; Dhodapkar, Madhav V; Nakamura, Ryotaro; Peyton, Kristin; Howard, Dianna S; Ibrahim, Uroosa; Shahid, Zainab; Armistead, Paul; Westervelt, Peter; McCarty, John; McGuirk, Joseph; Hamadani, Mehdi; DeWolf, Susan; Hosszu, Kinga; Sharon, Elad; Spahn, Ashley; Toor, Amir A; Waldvogel, Stephanie; Greenberger, Lee M; Auletta, Jeffery J; Horowitz, Mary M; Riches, Marcie L; Perales, Miguel-Angel